tiprankstipranks
Integrated BioPharma Inc (INBP)
OTHER OTC:INBP
US Market

Integrated BioPharma (INBP) Income Statement

Compare
8 Followers

Integrated BioPharma Income Statement

Last quarter (Q2 2025), Integrated BioPharma's total revenue was $1.17M, a decrease of -89.83% from the same quarter last year. In Q2, Integrated BioPharma's net income was $116.00K. See Integrated BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 50.32M$ 50.67M$ 56.25M$ 63.56M$ 52.77M
Gross Profit
$ 3.88M$ 4.06M$ 6.55M$ 9.48M$ 6.73M
Operating Expenses
$ 3.63M$ 3.94M$ 3.81M$ 3.70M$ 3.47M
Depreciation and Amortization
$ 1.22M$ 1.15M$ 834.00K$ 826.00K$ 772.00K
EBITDA
$ 1.47M$ 1.27M$ 3.56M$ 8.33M$ 4.26M
Operating Income
$ 251.00K$ 120.00K$ 1.97M$ 5.78M$ 2.38M
Other Income/Expenses
$ 17.00K$ -20.00K$ -148.00K$ 1.46M$ -171.00K
Pretax Income
$ 268.00K$ 100.00K$ 2.60M$ 7.25M$ 3.09M
Net Income
$ 112.00K$ -34.00K$ 3.84M$ 8.01M$ 4.11M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.00$ 0.00$ 0.13$ 0.27$ 0.14
Diluted EPS
$ 0.00$ 0.00$ 0.12$ 0.25$ 0.13
Weighted Average Shares Outstanding
30.07M 29.95M 29.84M 29.70M 29.57M
Weighted Average Shares Outstanding (Diluted)
30.87M 29.95M 32.32M 32.11M 31.16M
Currency in USD

Integrated BioPharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis